Skip to main content

Advertisement

Table 3 Histological changes between bicyclol group and ETV group after 48-week treatment

From: Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience

variables Bicyclol group (n = 30) ETV group (n = 30)
Inflammation activity, n (%)
 Inflammation improvement 16 (53.3) 19 (63.3)
 No change 12 (40.0) 10 (33.4)
 Inflammation progression 2 (6.7) 1 (3.3)
Liver Fibrosis, n (%)
 Fibrosis improvement 11 (36.7) 13 (43.4)
 No change 16 (53.3) 16 (53.3)
 Fibrosis progression 3 (10.0) 1 (3.3)